B型及C型肝炎诊断的全球市场 2023-2027

B型及C型肝炎诊断的市场规模在2022年～2027年间，预计将以年复合成长率6.12％成长到20亿5579万美元的规模。

本报告提供B型及C型肝炎诊断市场整体分析，提供市场规模与预测，趋势，成长促进因素，课题，再加上网罗了约25家供应商的供应商分析。

同时本报告还提供当前全球市场趋势与推动因素以及整体市场环境的最新分析。市场成长的主要因素有对分子诊断诊断 HBV 和 HCV 的需求不断增长、医疗机构简化诊断过程的战略以及对 POC 诊断需求不断增长。

目录

第1章 摘要整理

• 市场概要

第2章 市场形势

• 市场生态系统

第3章 市场规模

• 市场定义
• 市场区隔分析
• 市场规模 2022
• 市场预测:2022-2027年的预测

第4章 市场规模实际成果

• 全球B型及C型肝炎诊断市场2017～2021年
• 类型市场区隔分析2017-2021
• 疾病类型市场区隔分析2017-2021
• 地区市场区隔分析2017-2021
• 国家市场区隔分析2017-2021

第5章 波特的五力分析

• 五力的摘要
• 买方议价能力
• 供给企业谈判力
• 新加入厂商业者的威胁
• 替代品的威胁
• 竞争的威胁
• 市场情况

第6章 各类型的市场区隔

• 市场·市场区隔
• 各类型比较
• 免疫诊断 - 市场规模与预测 2022-2027
• NAT - 市场规模与预测 2022-2027
• 各类型的市场机会

第7章 各疾病类型市场区隔

• 市场·市场区隔
• 各疾病类型比较
• B型肝炎 - 市场规模与预测 2022-2027
• C型肝炎 - 市场规模与预测 2022-2027
• 各疾病的市场机会

第8章 客户形势

• 客户形势概要

第9章 各地区形势

• 各地区市场区隔
• 各地区比较
• 北美 - 市场规模与预测 2022-2027
• 欧洲 - 市场规模与预测 2022-2027
• 亚洲 - 市场规模与预测 2022-2027
• 其他地区(ROW) - 市场规模与预测 2022-2027
• 美国 - 市场规模与预测 2022-2027
• 德国 - 市场规模与预测 2022-2027
• 英国 - 市场规模与预测 2022-2027
• 日本 - 市场规模与预测 2022-2027
• 中国 - 市场规模与预测 2022-2027
• 各地区形势的市场机会

第10章 促进因素，课题，及趋势

• 推动市场要素
• 市场课题
• 推动因素与课题的影响
• 市场趋势

第11章 业者情势

• 概要
• 业者情势
• 混乱状况
• 产业的风险

第12章 供应商分析

• 交易厂商
• 供应商的市场定位
• Abbott Laboratories
• Bio Rad Laboratories Inc.
• bioMerieux SA
• DAAN Gene Co. Ltd.
• DiaSorin SpA
• Enzo Biochem Inc.
• F. Hoffmann La Roche Ltd.
• Grifols SA
• Hologic Inc.
• MedMira Inc.
• OraSure Technologies Inc.
• PerkinElmer Inc.
• QIAGEN NV
• Randox Laboratories Ltd.
• Siemens AG

第13章 附录

Technavio has been monitoring the hepatitis B and C diagnostics market and is forecast to grow by $2,055.79 mn during 2022-2027, decelerating at a CAGR of 6.12% during the forecast period. Our report on the hepatitis B and C diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for molecular diagnostics in diagnosis of HBV and HCV, strategies of healthcare organizations toward simplifying diagnostic process, and rising demand for POC diagnostics.

Technavio's hepatitis b and c diagnostics market is segmented as below:

By Type

• Immunodiagnostics
• NAT

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of immunosensors in HBV and HCV diagnostic tests as one of the prime reasons driving the hepatitis B and C diagnostics market growth during the next few years. Also, high demand for biomarker-based tests and increasing awareness and screening program of HBV and HCV diagnostic tests will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the hepatitis B and C diagnostics market covers the following areas:

• Hepatitis B and C diagnostics market sizing
• Hepatitis B and C diagnostics market forecast
• Hepatitis B and C diagnostics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis B and C diagnostics market vendors that include Abbott Laboratories, Bio Rad Laboratories Inc., bioMerieux SA, DAAN Gene Co. Ltd., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., MedMira Inc., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Quidel Corp., Randox Laboratories Ltd., Siemens AG, Sysmex Corp., and Xiamen Innovax Biotech Co. Ltd. Also, the hepatitis B and C diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Disease Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global hepatitis B and C diagnostics market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global hepatitis B and C diagnostics market 2017 - 2021 ($ million)
• 4.2 Procedure Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Procedure Segment 2017 - 2021 ($ million)
• 4.3 Diseases Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Diseases Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Immunodiagnostics - Market size and forecast 2022-2027
• Exhibit 34: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• 6.4 NAT - Market size and forecast 2022-2027
• Exhibit 38: Chart on NAT - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on NAT - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on NAT - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on NAT - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Type
• Exhibit 42: Market opportunity by Type ($ million)

7 Market Segmentation by Disease Type

• 7.1 Market segments
• Exhibit 43: Chart on Disease Type - Market share 2022-2027 (%)
• Exhibit 44: Data Table on Disease Type - Market share 2022-2027 (%)
• 7.2 Comparison by Disease Type
• Exhibit 45: Chart on Comparison by Disease Type
• Exhibit 46: Data Table on Comparison by Disease Type
• 7.3 Hepatitis B - Market size and forecast 2022-2027
• Exhibit 47: Chart on Hepatitis B - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Hepatitis B - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Hepatitis B - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Hepatitis B - Year-over-year growth 2022-2027 (%)
• 7.4 Hepatitis C - Market size and forecast 2022-2027
• Exhibit 51: Chart on Hepatitis C - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Hepatitis C - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Hepatitis C - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Hepatitis C - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Disease Type
• Exhibit 55: Market opportunity by Disease Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 59: Chart on Geographic comparison
• Exhibit 60: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.10 Japan - Market size and forecast 2022-2027
• Exhibit 89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.11 China - Market size and forecast 2022-2027
• Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 97: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 98: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 100: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 101: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 102: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 103: Matrix on vendor position and classification
• 12.3 Abbott Laboratories
• Exhibit 104: Abbott Laboratories - Overview
• Exhibit 105: Abbott Laboratories - Business segments
• Exhibit 106: Abbott Laboratories - Key news
• Exhibit 107: Abbott Laboratories - Key offerings
• Exhibit 108: Abbott Laboratories - Segment focus
• 12.4 Bio Rad Laboratories Inc.
• Exhibit 109: Bio Rad Laboratories Inc. - Overview
• Exhibit 110: Bio Rad Laboratories Inc. - Business segments
• Exhibit 111: Bio Rad Laboratories Inc. - Key news
• Exhibit 112: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 113: Bio Rad Laboratories Inc. - Segment focus
• 12.5 bioMerieux SA
• Exhibit 114: bioMerieux SA - Overview
• Exhibit 115: bioMerieux SA - Product / Service
• Exhibit 116: bioMerieux SA - Key offerings
• 12.6 DAAN Gene Co. Ltd.
• Exhibit 117: DAAN Gene Co. Ltd. - Overview
• Exhibit 118: DAAN Gene Co. Ltd. - Product / Service
• Exhibit 119: DAAN Gene Co. Ltd. - Key offerings
• 12.7 DiaSorin SpA
• Exhibit 120: DiaSorin SpA - Overview
• Exhibit 121: DiaSorin SpA - Business segments
• Exhibit 122: DiaSorin SpA - Key news
• Exhibit 123: DiaSorin SpA - Key offerings
• Exhibit 124: DiaSorin SpA - Segment focus
• 12.8 Enzo Biochem Inc.
• Exhibit 125: Enzo Biochem Inc. - Overview
• Exhibit 126: Enzo Biochem Inc. - Product / Service
• Exhibit 127: Enzo Biochem Inc. - Key offerings
• 12.9 F. Hoffmann La Roche Ltd.
• Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
• 12.10 Grifols SA
• Exhibit 133: Grifols SA - Overview
• Exhibit 134: Grifols SA - Business segments
• Exhibit 135: Grifols SA - Key offerings
• Exhibit 136: Grifols SA - Segment focus
• 12.11 Hologic Inc.
• Exhibit 137: Hologic Inc. - Overview
• Exhibit 138: Hologic Inc. - Business segments
• Exhibit 139: Hologic Inc. - Key news
• Exhibit 140: Hologic Inc. - Key offerings
• Exhibit 141: Hologic Inc. - Segment focus
• 12.12 MedMira Inc.
• Exhibit 142: MedMira Inc. - Overview
• Exhibit 143: MedMira Inc. - Product / Service
• Exhibit 144: MedMira Inc. - Key offerings
• 12.13 OraSure Technologies Inc.
• Exhibit 145: OraSure Technologies Inc. - Overview
• Exhibit 146: OraSure Technologies Inc. - Business segments
• Exhibit 147: OraSure Technologies Inc. - Key offerings
• Exhibit 148: OraSure Technologies Inc. - Segment focus
• 12.14 PerkinElmer Inc.
• Exhibit 149: PerkinElmer Inc. - Overview
• Exhibit 150: PerkinElmer Inc. - Business segments
• Exhibit 151: PerkinElmer Inc. - Key news
• Exhibit 152: PerkinElmer Inc. - Key offerings
• Exhibit 153: PerkinElmer Inc. - Segment focus
• 12.15 QIAGEN NV
• Exhibit 154: QIAGEN NV - Overview
• Exhibit 155: QIAGEN NV - Product / Service
• Exhibit 156: QIAGEN NV - Key news
• Exhibit 157: QIAGEN NV - Key offerings
• 12.16 Randox Laboratories Ltd.
• Exhibit 158: Randox Laboratories Ltd. - Overview
• Exhibit 159: Randox Laboratories Ltd. - Product / Service
• Exhibit 160: Randox Laboratories Ltd. - Key offerings
• 12.17 Siemens AG
• Exhibit 161: Siemens AG - Overview
• Exhibit 162: Siemens AG - Business segments
• Exhibit 163: Siemens AG - Key news
• Exhibit 164: Siemens AG - Key offerings
• Exhibit 165: Siemens AG - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 166: Inclusions checklist
• Exhibit 167: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 168: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 169: Research methodology
• Exhibit 170: Validation techniques employed for market sizing
• Exhibit 171: Information sources
• 13.5 List of abbreviations
• Exhibit 172: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Disease Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global hepatitis B and C diagnostics market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Procedure Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Diseases Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Type - Market share 2022-2027 (%)
• Exhibits31: Data Table on Type - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on NAT - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on NAT - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on NAT - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on NAT - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Type ($ million)
• Exhibits43: Chart on Disease Type - Market share 2022-2027 (%)
• Exhibits44: Data Table on Disease Type - Market share 2022-2027 (%)
• Exhibits45: Chart on Comparison by Disease Type
• Exhibits46: Data Table on Comparison by Disease Type
• Exhibits47: Chart on Hepatitis B - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Data Table on Hepatitis B - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Chart on Hepatitis B - Year-over-year growth 2022-2027 (%)
• Exhibits50: Data Table on Hepatitis B - Year-over-year growth 2022-2027 (%)
• Exhibits51: Chart on Hepatitis C - Market size and forecast 2022-2027 ($ million)
• Exhibits52: Data Table on Hepatitis C - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Chart on Hepatitis C - Year-over-year growth 2022-2027 (%)
• Exhibits54: Data Table on Hepatitis C - Year-over-year growth 2022-2027 (%)
• Exhibits55: Market opportunity by Disease Type ($ million)
• Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits59: Chart on Geographic comparison
• Exhibits60: Data Table on Geographic comparison
• Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits97: Market opportunity By Geographical Landscape ($ million)
• Exhibits98: Impact of drivers and challenges in 2022 and 2027
• Exhibits99: Overview on Criticality of inputs and Factors of differentiation
• Exhibits100: Overview on factors of disruption
• Exhibits101: Impact of key risks on business
• Exhibits102: Vendors covered
• Exhibits103: Matrix on vendor position and classification
• Exhibits104: Abbott Laboratories - Overview
• Exhibits105: Abbott Laboratories - Business segments
• Exhibits106: Abbott Laboratories - Key news
• Exhibits107: Abbott Laboratories - Key offerings
• Exhibits108: Abbott Laboratories - Segment focus
• Exhibits109: Bio Rad Laboratories Inc. - Overview
• Exhibits110: Bio Rad Laboratories Inc. - Business segments
• Exhibits111: Bio Rad Laboratories Inc. - Key news
• Exhibits112: Bio Rad Laboratories Inc. - Key offerings
• Exhibits113: Bio Rad Laboratories Inc. - Segment focus
• Exhibits114: bioMerieux SA - Overview
• Exhibits115: bioMerieux SA - Product / Service
• Exhibits116: bioMerieux SA - Key offerings
• Exhibits117: DAAN Gene Co. Ltd. - Overview
• Exhibits118: DAAN Gene Co. Ltd. - Product / Service
• Exhibits119: DAAN Gene Co. Ltd. - Key offerings
• Exhibits120: DiaSorin SpA - Overview
• Exhibits121: DiaSorin SpA - Business segments
• Exhibits122: DiaSorin SpA - Key news
• Exhibits123: DiaSorin SpA - Key offerings
• Exhibits124: DiaSorin SpA - Segment focus
• Exhibits125: Enzo Biochem Inc. - Overview
• Exhibits126: Enzo Biochem Inc. - Product / Service
• Exhibits127: Enzo Biochem Inc. - Key offerings
• Exhibits128: F. Hoffmann La Roche Ltd. - Overview
• Exhibits129: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits130: F. Hoffmann La Roche Ltd. - Key news
• Exhibits131: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits132: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits133: Grifols SA - Overview
• Exhibits134: Grifols SA - Business segments
• Exhibits135: Grifols SA - Key offerings
• Exhibits136: Grifols SA - Segment focus
• Exhibits137: Hologic Inc. - Overview
• Exhibits138: Hologic Inc. - Business segments
• Exhibits139: Hologic Inc. - Key news
• Exhibits140: Hologic Inc. - Key offerings
• Exhibits141: Hologic Inc. - Segment focus
• Exhibits142: MedMira Inc. - Overview
• Exhibits143: MedMira Inc. - Product / Service
• Exhibits144: MedMira Inc. - Key offerings
• Exhibits145: OraSure Technologies Inc. - Overview
• Exhibits146: OraSure Technologies Inc. - Business segments
• Exhibits147: OraSure Technologies Inc. - Key offerings
• Exhibits148: OraSure Technologies Inc. - Segment focus
• Exhibits149: PerkinElmer Inc. - Overview
• Exhibits150: PerkinElmer Inc. - Business segments
• Exhibits151: PerkinElmer Inc. - Key news
• Exhibits152: PerkinElmer Inc. - Key offerings
• Exhibits153: PerkinElmer Inc. - Segment focus
• Exhibits154: QIAGEN NV - Overview
• Exhibits155: QIAGEN NV - Product / Service
• Exhibits156: QIAGEN NV - Key news
• Exhibits157: QIAGEN NV - Key offerings
• Exhibits158: Randox Laboratories Ltd. - Overview
• Exhibits159: Randox Laboratories Ltd. - Product / Service
• Exhibits160: Randox Laboratories Ltd. - Key offerings
• Exhibits161: Siemens AG - Overview
• Exhibits162: Siemens AG - Business segments
• Exhibits163: Siemens AG - Key news
• Exhibits164: Siemens AG - Key offerings
• Exhibits165: Siemens AG - Segment focus
• Exhibits166: Inclusions checklist
• Exhibits167: Exclusions checklist
• Exhibits168: Currency conversion rates for US$
• Exhibits169: Research methodology
• Exhibits170: Validation techniques employed for market sizing
• Exhibits171: Information sources
• Exhibits172: List of abbreviations